Gilead Sciences has committed to implementing Veeva Systems’ (NYSE:VEEV) Vault CRM platform, according to a press release statement issued Wednesday. InvestingPro data shows Veeva commands a substantial market presence with a $46.12 billion market capitalization and maintains excellent financial health with a "GREAT" overall score.
The biopharmaceutical company will expand its existing partnership with Veeva by adopting the customer relationship management solution, which is part of the Vault CRM Suite of applications designed for commercial execution in the life sciences industry.
The Vault CRM platform includes Veeva AI capabilities that provide multiple AI agents for functions such as pre-call planning, compliant free text, and voice control, aimed at enhancing commercial efficiency.
https://www.investing.com/news/company-news/gilead-sciences-commits-to-veeva-vault-crm-93CH-4233764
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.